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ORIGINAL ARTICLE
G2A Attenuates Propionibacterium acnes Induction 
of Inflammatory Cytokines in Human Monocytes
Andrew J Park1,2,*, George W Agak1,*, Min Qin1, Lisa D Hisaw1, Aslan Pirouz1, Stephanie Kao1, 
Laura J Marinelli1,3, Hermes J Garbán1, Diane Thiboutot4, Philip T Liu5,†, Jenny Kim1,†
1Division of Dermatology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, 
CA, 2Geisel School of Medicine, Dartmouth College, Hanover, NH, 3Department of Microbiology, Immunology, and Molecular Genetics, 
David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, 4Department of Dermatology, Penn State 
University College of Medicine, Hershey, PA, 5Department of Orthopedic Surgery, Orthopedic Hospital Research Center, David Geffen 
School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA 
Background: Acne vulgaris is a disease of the pilosebaceous 
unit characterized by increased sebum production, hyper-
keratinization, and immune responses to Propionibacterium 
acnes (PA). Here, we explore a possible mechanism by 
which a lipid receptor, G2A, regulates immune responses to 
a commensal bacterium. Objective: To elucidate the in-
flammatory properties of G2A in monocytes in response to 
PA stimulation. Furthermore, our study sought to investigate 
pathways by which lipids modulate immune responses in re-
sponse to PA. Methods: Our studies focused on monocytes 
collected from human peripheral blood mononuclear cells, 
the monocytic cell line THP-1, and a lab strain of PA. Our 
studies involved the use of enzyme-linked immunosorbent, 
Western blot, reverse transcription polymerase chain re-
action, small interfering RNA (siRNA), and microarray analy-
sis of human acne lesions in the measurements of in-
flammatory markers. Results: G2A gene expression is higher 
in acne lesions compared to normal skin and is inducible by 
the acne therapeutic, 13-cis-retinoic acid. In vitro, PA in-
duces both the Toll-like receptor 2-dependent expression of 
G2A as well as the production of the G2A ligand, 9-hydrox-
yoctadecadienoic acid, from human monocytes. G2A gene 
knockdown through siRNA enhances PA stimulation of in-
terleukin (IL)-6, IL-8, and IL-1β possibly through increased 
activation of the ERK1/2 MAP kinase and nuclear factor kap-
pa B p65 pathways. Conclusion: G2A may play a role in quel-
ling inflammatory cytokine response to PA, revealing G2A as 
a potential attenuator of inflammatory response in a disease 
associated with a commensal bacterium. (Ann Dermatol 
29(6) 688∼698, 2017)
-Keywords-
9-HODE, Acne vulgaris, G2A, G protein-coupled receptor 
132, Isotretinoin
INTRODUCTION
Acne vulgaris is a common skin disease that affects up-
wards of 85% of adolescents and frequently persists into 
adulthood. It is a disease of the pilosebaceous unit that is 
classically associated with hyperkeratinization, increased 
sebum production, and an inflammatory cytokine response 
thought to be triggered by the commensal bacterium 
Propionibacterium acnes (PA)1,2. Its pathogenesis is multi-
factorial and thought to involve complex and poorly un-
derstood lipid-associated pathways. Some observational 
studies show that abnormal sebum lipid composition is as-
sociated with worsened disease and that acne patients 
have low linoleate levels in skin while high levels prevent 
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comedogenesis3. PA also metabolizes triglycerides into 
free fatty acids (FFAs) in the pilosebaceous unit and the 
density of PA is positively correlated with sebum secretion 
rate4. However, how lipids are directly involved in in-
flammatory responses seen in acne remains unclear.
G2A, also known as G protein-coupled receptor 132 
(GPCR 132), is a stress-inducible GPCR and known re-
ceptor for oxidized lipids, with especially high affinity for 
the linoleic acid derivative 9-hydroxyoctadecadienoic acid 
(9-HODE). Linoleic acid is found in relatively high con-
centrations in sebum and is one of the FFAs known to un-
dergo beta-oxidation in the pilosebaceous unit. In part due 
to its recent discovery, the immunologic roles of G2A still 
remain unclear. Models of atherosclerosis suggest an an-
ti-inflammatory role as mice lacking G2A had greater ac-
cumulation of macrophages on the aortic wall, increased 
nuclear localization of nuclear factor-κB (NF-κB) p65 
subunit, and increased IL-6 and monocyte chemoattractant 
protein-15. In contrast, studies in keratinocytes suggest a 
more pro-inflammatory role6.
Its role in skin disease and in response to microflora are 
emerging areas of interest. G2A was recently shown to 
mediate interactions between the host and gastrointestinal 
microflora. Bacteroides induced endogenous stimulation 
of G2A and is thought to quell immune responses; thus, 
G2A may also have a role in autoimmunity7. As G2A is al-
so expressed in skin, it is hypothesized that this GPCR 
may also play a role in regulating the skin’s immune re-
sponse to environmental factors and the interaction be-
tween skin and its microflora1,2,8 .
Our study is the first to investigate the role of G2A in the 
context of a commensal skin bacterium. Studying G2A in 
the context of PA provides an opportunity for the under-
standing of acne pathogenesis and G2A as an immune 
regulator. First, while PA colonization, sebum production, 
and inflammatory cytokine induction are inextricably 
linked in acne9-11, the consequences of lipid involvement 
and inflammation potentially cross-regulating pathways at 
a sight of colonization remains elusive. Second, under-
standing the role of G2A in response to PA will help de-
fine the immunomodulatory properties of this receptor in 
the context of bacteria and help delineate underlying 
mechanisms by which inflammatory responses to a com-
mensal organism can be mediated12. Our study uses hu-
man monocytes to characterize these properties of G2A 
and also considers the potential clinical relevance of G2A 
in acne.
MATERIALS AND METHODS
Monocyte isolation
Human monocyte isolation followed protocol described 
by Schenk et al.13. Peripheral blood mononuclear cells 
(PBMCs) obtained from donors after consent approved by 
the UCLA Institutional Review Board in accordance with 
Declaration of Helsinki Principles. PBMCs isolated using 
Ficoll (GE Healthcare, Uppsala, Sweden) gradient cent-
rifugation. Monocytes enriched with Percoll density gra-
dient (GE Healthcare) and adherence in RPMI 1640 me-
dium (Thermo Fisher Scientific) with 1% fetal calf serum 
(FCS; Omega Scientific, Tarzana, CA, USA) for 2 h. Ad-
herent monocytes cultured in 10% FCS. Monocyte purity 
＞80% as measured by CD14 expression.
PA culture 
PA strain 6919 obtained from American Type Culture 
Collections (ATCC; Manassas, VA, USA) and grown on 
brucella agar with 5% sheep blood, hemin, and vitamin K 
(Thermo Fisher Scientific Remel Productions, Lenexa, KS, 
USA) at 37oC for 3∼5 days in sealed chambers with 
Anaero Packs (Mitsubishi Gas Chemical Co., Inc., Tokyo, 
Japan). Cultures grown under same conditions in rein-
forced clostridial medium (Oxoid, Basingstoke, England). 
Spectrophotometer OD600 used to determine bacterial log 
phase. Cultures diluted to final concentration of 0.5 multi-
plicity of infection (MOI) to stimulate cells. 
Quantification of HODEs and hydroxyeicosatetraenoic 
acids by LC/MS/MS
Supernatants from monocytes stimulated for 24 hours with 
0.5 MOI PA were processed to measure concentrations of 
HODEs and hydroxyeicosatetraenoic acids (HETEs) using 
method adopted from Imaizumi et al.14 LC/MS/MS per-
formed using 4000 QTRAP (Applied Biosystems, Foster 
City, CA, USA) with electrospray ionization (ESI) source. 
High-performance liquid chromatography (HPLC) system 
used Agilent 1200 series LC pump with thermostatted au-
tosampler (Agilent Technologies, Santa Clara, CA, USA). 
Chromatography performed using Luna C-18(2) column (3 
μm particle, 150×3.0 mm). Data acquisitions and instru-
ment control done with Analyst 1.4.2 software (Applied 
Biosystems). Detection accomplished with multiple reac-
tion monitoring modes with negative ion detection. Colli-
sion energy, declustering potential, and collision cell exit 
potential optimized for each compound to obtain optimum 
sensitivity. Transitions monitored were mass-to-charge ratio 
(m/z): m/z 295.1→194.8 for 13-HODE; 295.0→171.0 for 
9-HODE; 319.1→219.0 for 15-HETE; 319.1→115.0 for 
5-HETE; 319→179 for 12-HETE.
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Cytokine measurements by enzyme-linked 
immunosorbent assay
IL-6, IL-8, and IL-1β levels in culture supernatants quanti-
fied by enzyme-linked immunosorbent assay (ELISA) using 
cytokine-specific capture antibodies and secondary bio-
tin-conjugated antibodies (Thermo Fisher Scientific) in ref-
erence to recombinant proteins (eBioscience, San Diego, 
CA, USA) in 96-well plates (Corning, NY, USA). Plates 
blocked using phosphate-buffered saline (PBS) solution 
with 10% bovine serum albumin (BSA; Thermo Fisher 
Scientific, Waltham, MA, USA). Plates washed with PBS 
containing 0.005% Tween 20 (Sigma-Aldrich, St. Louis, 
MO, USA). Samples were assayed in triplicates.
RNA isolation, cDNA synthesis, and quantitative 
polymerase chain reaction 
Total RNA isolated using Trizol reagent (Thermo Fisher 
Scientific) following manufacturer’s recommendations and 
treated with RNase-free DNase. RNA isolated with 
Quick-RNA MiniPrep kit (Zymo Research, Irvine, CA, 
USA). RNA concentration and quality determined by spec-
trophotometry at OD460 and OD480. Samples reverse tran-
scribed with iScript cDNA synthesis kit (Bio-Rad, Hercules, 
CA, USA) at 25oC 5 minutes, 42oC 30 minutes, and 85oC 
5 minutes. Quantitative polymerase chain reaction (qPCR) 
performed using iQ SYBR Green Supermix (Bio-Rad) (40 
cycles of 95°C 5 minutes, 95°C 10 seconds, 55°C 20 sec-
onds, and 72°C 20 seconds). Glyceraldehyde-3-phosphate 
dehydrogenase amplification used as internal standard. 
Primers designed using Primer Express (Applied Biosystems). 
Gene expression level quantified by comparative method 
2−ΔΔCT.
Flow cytometry
Cells for detection of G2A treated with 0.5 MOI PA, iso-
tretinoin, and/or all-trans-retinoic acid (ATRA) incubated 
with anti-G2A polyclonal antibody (MBL International; 
Woburn, MA, USA), Immunoglobulin (Ig)G isotype con-
trol (Santa Cruz Biotechnology, Santa Cruz, CA, USA), and 
secondary Alexa Fluor 488-conjugated antibody (Thermo 
Fisher Scientific). Between incubation steps, cells washed 
with PBS containing 1% bovine serum albumin. Cells fixed 
with 2% paraformaldehyde (Thermo Fisher Scientific), ac-
quired on BD FACScan System, and analyzed using 
CellQuest-Pro software (BD, Franklin Lakes, NJ, USA).
Small interfering RNA transfection
Small interfering RNA (siRNA) transfection performed with 
Lonza Nucleofector system with either the Lonza Human 
Monocyte Nucleofector kit or Lonza Cell Line Nucleofector 
kit V for human promyelocytic cell line THP-1 (Lonza, 
Basel, Switzerland). Scramble control and anti-G2A siRNA 
constructs were used at 1 μg per transfection (Thermo 
Fisher Scientific). Transfection efficiency of expression 
constructs assessed using the pmax-GFP construct (Lonza), 
and yielded average of 50% transfection rate.
Western blot analysis 
Detections of phospho-p44/42 mitogen-activated protein 
kinase (MAPK), phospho-p38 MAPK, and NF-κB p65 
were performed using western blot. After PA treatment, 
cells lysed in buffer containing 1% Triton X-100 
(Sigma-Aldrich) and Protease/Phosphotase Inhibitor Cocktail 
(Cell Signaling, Danvers, MA, USA). Protein concen-
trations assessed with Quick Start Bradford Protein Assay 
kit following manufacturer’s protocol. Lysates loaded with 
Laemmli Sample Buffer onto Any kD Mini-PROTEAN-TGX 
pre-cast polyacrylamide gel (Bio-Rad) and separated by 
electrophoresis. Gels transferred onto polyvinylidene di-
fluoride membranes (EMD Millipore, Billerica, MA, USA) 
and detected with primary antibodies for MAPK (Cell 
Signaling) or NF-κB (Sigma-Aldrich) pathways, secondary 
horse radish peroxidase-conjugated antibody (Abcam, 
Cambridge, England), and chemiluminescent substrate 
(Thermo Fisher Scientific) before visualization with 
ChemiDoc MP System (Bio-Rad). 
Microarray of acne lesions 
Total RNA from five acne lesions and five matched non-le-
sional controls was obtained from Diane Thiboutot 
(Pennsylvania State University, Hershey, PA, USA)15. 
Biopsies taken from backs of men and women without 
other skin diseases in biopsy areas. Gene expression pro-
files were re-measured using the Affymetrix GeneChip, 
Human Genome (HG)-U133A Plus 2.0 array platform to 
include GPR132, which was not included in the Trivedi et 
al. report15. Data analyzed as previously described16. 
Analysis identified 890 genes that were significantly ele-
vated in acne lesions (fold-change≥1.5 and p＜0.05), 
compared to controls. 
Other reagents
Neutralizing antibodies against Toll-like receptor 2 (TLR2) 
and TLR4, and control antibodies (BioLegend, San Diego, 
CA, USA); 9(S)-HODE (Cayman Chemical Company, Ann 
Arbor, MI, USA); human acute monocytic leukemia cell line 
THP-1 (ATCC) cultured in RPMI Medium 1640 supple-
mented with 10% FCS, 1% Sodium Pyruvate (Thermo 
Fisher Scientific), and Penicillin-Streptomycin-L-Glutamine 
(Corning); Tris/Glycine and Tris/Glyine/SDS buffers and 
blotting-grade blocker for western blot (Bio-Rad); all-trans- 
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Fig. 1. Propionibacterium acnes (PA), but not 9-hydroxyoctadecadienoic acid (9-HODE), upregulates G2A in monocytes via a Toll-like 
receptor 2 (TLR2)-dependent mechanism. (A) Quantitative polymerase chain reaction (qPCR) and (B) fluorescence-activated cell sorting 
(FACS) analysis revealed that PA, but not 9-HODE, upregulates both the mRNA expression and the population of cells expressing 
G2A in both the THP-1 cell line and in primary human monocytes. Values from PCR are shown as mean±standard error (SE) (n=4) 
and FACS data is representative of three independent experiments. (C) Blocking antibody to TLR2 neutralized the upregulation of 
G2A mRNA expression by PA in monocytes. Values are expressed as mean±standard error (n=3). MOI: multiplicity of infection, 
IgG: immunoglobulin G. *p＜0.05, **p＜0.01.
retinoic acid (retinoic acid) and isotretinoin (13-cis-retinoic 
acid [13cRA]) (Sigma-Aldrich) reconstituted in dimethyl 
sulfoxide (Thermo Fisher Scientific).
Statistical analysis
Results expressed as means±standard error (SE) for the 
number of separate experiments indicated in each Fig. 1∼
AJ Park, et al
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Fig. 2. Induction of 9-hydroxyoctadecadienoic acid (9-HODE) in 
human monocytes by Propionibacterium acnes (PA). Mass spec-
trometry analysis of G2A ligand and linoleic acid derivative, 
9-HODE, and arachidonic acid derivative, 15-hydroxyeicosate-
traenoic acids, in human monocytes by PA. Values are expressed 
as mean±standard error and were compiled from three 
independent experiments. MOI: multiplicity of infection. *p
＜0.05, **p＜0.001.
5. Post hoc two-tailed Student’s t-test used for comparison 
between two groups. For Fig. 4, 5B, to address increased 
likelihood of Type I errors when making comparisons over 
multiple groups, p-values adjusted using Bonferroni 
correction. For Fig. 5A, post hoc two-tailed paired t-test 
performed to ensure analysis of paired samples. Significant 
differences considered for those with p-values ≤0.05.
RESULTS 
GPR132 expression in monocytes upregulated by PA via 
TLR2
To test G2A expression under different conditions, we ex-
amined the effects of 9(S)-HODE and PA on THP-1 cells 
and primary human monocytes. G2A mRNA expression 
or the population of cells expressing G2A in either THP-1 
or monocytes was unchanged after treatment with differ-
ent concentrations of 9(S)-HODE (Fig. 1A). In contrast, PA 
exposure increased the population of THP-1 cells express-
ing G2A approximately 35-fold compared to isotype con-
trol (Fig. 1B), and increased the gene expression of 
GPR132 in both THP-1 and monocytes by approximately 
50% and 40%, respectively (Fig. 1A, p＜0.05). We next as-
sessed the effect of TLR2, an important mediator of innate 
immune system in response to PA17. We observed a sig-
nificant 30% reduction in GPR132 expression in mono-
cytes pre-treated with TLR2 neutralizing antibody prior to 
addition of PA, as compared to the isotype control (Fig. 
1C, p＜0.01). 
G2A ligand, 9-HODE, is upregulated by PA in human 
monocytes
9-HODE is a known ligand of G2A1,2. We sought to char-
acterize the baseline levels of this ligand and related oxi-
dized lipids produced from human monocytes as well as 
their inducibility with PA. Monocytes were treated with 
PA for 24 hours; then cell lysates were purified and ana-
lyzed with liquid chromatography and tandem mass 
spectrometry. We measured the oxidized forms of linoleic 
acid, 9-HODE and 13-HODE, as well as three oxidized 
forms of another FFA, arachidonic acid, 5-, 12-, and 
15-HETE. Both 9-HODE and 13-HODE were found in sig-
nificantly higher concentrations (5-fold and 10-fold, re-
spectively) than all three HETEs. Exposing monocytes to PA 
increased the concentration of 9-HODE by approximately 
2-fold (Fig. 2, p＜0.001), whereas 13-HODE was not sig-
nificantly altered. Of the three HETEs measured, only 
15-HETE was found to be significantly upregulated by PA 
(p＜0.05); however, its concentration was notably less 
than the concentrations of both the HODEs.
GPR132 knockdown monocytes exhibit increased 
inflammatory response
To understand the immunomodulatory functions of G2A, 
we transfected THP-1 cells using siRNA oligonucleotides 
specific to G2A mRNA (siG2A), then measured gene ex-
pression and protein secretion of inflammatory cytokines 
IL-6, IL-8, and IL-1β, following exposure to PA. Our trans-
fection methods consistently yielded approximately 50% 
knockdown of G2A mRNA expression when compared to 
the non-targeting oligonucleotide control (siCTRL) (Supple-
mentary Fig. 1, p＜0.05). Knockdown of the G2A gene in 
THP-1 cells led to an increase in inflammatory cytokines 
both in response to PA and G2A ligand 9(S)-HODE. A 24 
hours incubation of siG2A transfected THP-1 cells with 
live PA resulted in increases of approximately 1.8-fold for 
IL-6 (Fig. 3A, p＜0.01) and 1.3-fold for IL-8 (Fig. 3C, p＜ 
0.05), but no change in IL-1β; when compared to control 
(Fig. 3E). At the mRNA level, G2A knockdown in THP-1 
cells stimulated with PA resulted in approximately 2.2-fold 
increase of IL6 (Fig. 3B, p＜0.01), 3.9-fold increase of IL8 
(Fig. 3D, p＜0.01), and 1.9-fold increase of IL1B (Fig. 3F, 
p＜0.05) mRNA when compared to control. G2A knock-
down THP-1 cells treated with 9(S)-HODE exhibited in-
creases of approximately 2.7-fold for IL6 (Fig. 3B, p＜ 
0.05), 1.2-fold increase for IL8 (Fig. 3D, p＜0.05), and 
1.4-fold increase for IL1B (Fig. 3F, p＜0.001) when com-
pared to control. At the protein level, there was nearly a 
2.3-fold increase of IL-8 (Fig. 3C, p＜0.05) when compar-
ing PA-stimulated cells transfected with siG2A to siCTRL, 
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Fig. 3. Effects of G2A knockdown on interleukin (IL)-6, IL-8, and IL-1β cytokine secretion and gene expression. The secreted protein 
and mRNA from G2A knockdown THP-1 cells were analyzed using enzyme-linked immunosorbent and quantitative polymerase chain 
reaction. (A) G2A knockdown enhanced IL-6 secretion in response to Propionibacterium acnes (PA) and (B) upregulation of IL6 gene 
expression in response to PA and 9-hydroxyoctadecadienoic acid (9-HODE). (C) G2A knockdown enhanced IL-8 response to PA and 
9-HODE both at the protein level and the gene (D) level. (E) G2A knockdown had no measureable effect on IL-1β cytokine response 
to PA or 9-HODE, (F) but enhanced IL-1β response to PA and 9-HODE at the gene level. Values are expressed as mean±standard
error (n=4). siRNA: small interfering RNA. *p＜0.05, **p＜0.01, ***p＜0.001.
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Fig. 4. Effects of G2A knockdown on ERK1/2 and nuclear factor 
kappa B (NF-κB) p65 activation. (A∼C) Western blot studies 
on human monocytes using an anti-G2A small interfering RNA 
(siRNA). G2A was partially knocked down in human monocytes 
using an anti-G2A siRNA. These cells were then analyzed using 
western blot to measure differences in activation of select 
molecular pathways in response to Propionibacterium acnes 
(PA). *p＜0.05. 
while levels of IL-6 and IL-1β were not significantly 
changed. 
Knockdown of GPR132 in monocytes results in an 
increase in the activation of ERK1/2 and NF-κB p65 
pathway
The MAPK and NF-κB pathways are thought to be integral 
in the regulation of inflammatory cytokines IL-6 and IL-8. 
To elucidate the signaling pathways that are activated by 
G2A to regulate inflammatory response, we measured the 
phosphorylation of two MAPK pathways, ERK1/2 (p44/42) 
and p38 MAPK, and NF-κB p65 using western blot. 
Densitometric analysis of blot bands showed that the G2A 
knockdown in monocytes stimulated with PA exhibited ap-
proximately 2.3-fold increase in the phosphorylation of the 
ERK1/2 MAPK pathway compared to control (Fig. 4A, p＜ 
0.01), and nearly a 1.5-fold increase in NF-κB p65 sub-
unit (Fig. 4C, p＜0.05). PA induced approximately a 50% 
increase in the phosphorylation of p38 MAPK in the 
scramble control group (Fig. 4B, p＜0.05); however, this 
was not found to be significantly modulated by the G2A 
knockdown.
GPR132 is upregulated in acne lesions
To explore the potential clinical implications of G2A in 
acne, we compared the mRNA profile of acne lesions to 
normal skin. Total RNA samples from punch biopsies of 
five acne lesions and matched non-lesional controls 
(normal skin) were obtained from D. Thiboutot15. mRNA 
expression profiles were assessed using Affymetrix gene 
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Fig. 5. G2A mRNA expression in acne lesions and human 
monocytes. (A) Assessment of RNA isolated from acne lesions 
and matched normal skin revealed an increase in the gene 
expression for G2A, GPR132. Also shown are the negative and 
positive controls, SCGB1D2 and DEFB4, respectively. Values 
connected by points are from individual donors and values 
expressed by a bar are mean values (n=5). (B) G2A expression 
in human monocytes in response to Propionibacterium acnes, 
all-trans-retinoic acid (ATRA), and 13-cis-retinoic acid (13cRA) 
as measured by fluorescence-activated cell sorting analysis. 
Values are expressed as percentage of cells expressing G2A 
(n=3). *p＜0.05, **p＜0.01, ***p＜0.001.
expression microarray system. For each of the donors, 
G2A mRNA expression (GPR132) was higher in the acne 
lesion biopsies than in the matched controls. When the 
expression values of donors were averaged, the mean 
GPR132 expression was doubled (Fig. 5A, p＜0.001) in 
acne lesions compared to normal skin. Comparison of se-
cretoglobin SCGB1D2 (p＜0.01) and human beta-defensin 
4 DEFB4 (p＜0.05) from the current data set corroborates 
previously published microarray data obtained from the 
same lesional and control samples using a previous ver-
sion of the Affymetrix human array (U133A 2.0)15.
PA and isotretinoin, but not all-trans-retinoic acid, 
upregulate G2A in human monocytes 
Retinoids, a class of vitamin A-derived compounds that 
bind various members of the retinoic acid receptor18-20, af-
fect keratinocyte maturation and anti-inflammatory activ-
ity21,22. Retinoids also downregulate TLR2 expression in 
monocytes23. We investigated whether 13cRA and ATRA, 
two widely used therapeutics for acne24,25 could regulate 
G2A expression in monocytes. Monocytes were pre-treat-
ed with 13cRA and ATRA for 1 hour prior to a 24 hours 
exposure to live PA. These monocytes were then labeled 
with anti-G2A antibodies and analyzed using flow 
cytometry. Compared to control, ATRA alone did not in-
duce a significant change in the percentage of cells ex-
pressing G2A but 13cRA induced a 10-fold increase (Fig. 
5B, p＜0.001). When exposed to PA, monocytes ex-
hibited a 100-fold increase in the percentage of cells ex-
pressing G2A compared to untreated cells (p＜0.0001). 
Concurrent treatment with ATRA did not significantly 
modulate the PA-induced upregulation of G2A whereas 
13cRA increased G2A expression on monocytes by ap-
proximately 30% compared to PA alone (p＜0.05). 
DISCUSSION 
The active disease site of acne is the pilosebaceous unit, a 
lipid-rich environment where the commensal microbe PA 
colonizes and can induce inflammation. While increased 
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sebum production is observed in acne, the mechanism by 
which lipids play a role in pathogenesis remains unclear. 
G2A provides one model that illustrates how lipid re-
ceptors may attenuate inflammation to a bacterium and 
regulate immune response to normal skin microflora. 
We studied G2A in response to PA in human monocytes 
given previous studies showing relatively high levels of 
G2A monocyte expression and that monocytes are con-
sistently used to study inflammatory responses to PA5,17,26,27. 
First, we found that both G2A is inducible by PA and may 
potentiate an anti-inflammatory cascade, as we see 
through our G2A knockdown model leading to upregula-
tion of pro-inflammatory cytokines: IL-6, IL-8, and IL-1β, 
markers associated with PA-induced inflammation28. These 
cytokines play pivotal roles in host defense29, neutrophil 
signaling, lysosomal pathways30, and early innate immune 
responses to bacterial pathogens31.
G2A has high affinity for the stable oxidized linoleic acid 
derivative, 9-HODE17. We show that the G2A ligand, 
9-HODE, is also found in higher concentrations from 
monocytes in response to PA, presumably through an oxi-
dative process, thus introducing a possible pathway by 
which oxidative changes to FFAs modulate downstream in-
flammatory responses. The inflammatory properties of 
9-HODE has not been characterized in skin. However, 
there are studies from the atherosclerosis model that show 
that these lipids play a role in regulating monocyte func-
tion, such as retaining monocytes at the sites of in-
flammation32,33. We acknowledge, however, that our find-
ings can only suggest a possible autocrine or paracrine re-
sponse among monocytes and does not completely model 
the interaction between G2A and 9-HODE from sebum 
and resident skin cells. 
In response to PA exposure, G2A response appears con-
nected to innate immune pathways as its effects are parti-
ally mediated by TLR2, which is sufficient for the activa-
tion of NF-κB in response to PA exposure required for the 
later downstream pro-inflammatory cytokine promoter ac-
tivity17. We observed a significant 30% reduction in G2A 
expression in monocytes treated with TLR2 neutralizing 
antibody as compared to cells pretreated with IgG isotype 
control. Furthermore, TLR downstream signaling pathways 
ERK1/2 MAPK and NF-κB p65, but not the p38 pathway, 
was reduced following PA simulation in G2A-knockdown 
monocytes. This discrepancy of MAP kinase pathway acti-
vation is also seen in other models34, such as in osteo-
blasts and corneal epithelial35. One possible explanation 
for this bifurcation may be due to the known differences 
of p44/42 versus p38 MAP kinase pathways—e.g., the 
p44/42 isoforms of MAP kinase are more associated with 
growth factors and GPCRs. The question of whether there 
is crosstalk between G2A, a GPCR, and TLR2; or whether 
these two receptors modulate activation of NF-κB and 
MAP kinase independent of one another remains to be 
elucidated. However, there is a growing body of knowl-
edge that shows how GPCRs and TLRs can exhibit recip-
rocal activity by regulating the signaling of each other36. 
By looking at the effects of retinoic acids on G2A and ana-
lyzing RNA samples from acne lesions, we sought to asso-
ciate G2A to the clinical setting. One of the desired out-
comes of isotretinoin treatment is a reduction of in-
flammation by a mechanism incompletely understood37,38. 
Given that isotretinoin induced higher expression of G2A 
in monocytes, and attenuated pro-inflammatory cytokines 
IL-6 and IL-8, this mechanism may suggest that this reduc-
tion in inflammation clinically may be associated with its 
effect on G2A36,39-42. Our findings that G2A is upregulated 
in monocytes in response to PA was mirrored in acne le-
sion punch biopsies compared to matched normal skin. 
While acne lesions are characterized by increased in-
flammation, it is known that there are concurrent anti-in-
flammatory and anti-microbial pathways that are activated 
during disease, such as through antimicrobial peptides 
and IL-1043,44. While our skin biopsies contain a milieu of 
both resident skin cells and immune cells, the general up-
regulation of G2A in the skin as well as in monocytes may 
act as one of these anti-inflammatory pathways. 
Our main goals in studying G2A were to define a possible 
mechanism by which lipids mediate inflammation in re-
sponse to the PA and to further elucidate the immune reg-
ulatory roles of this receptor, especially in light of recent 
findings that G2A may be important in regulating im-
munity to commensal bacteria. Yet an important question 
that remains is whether G2A expression correlates with 
acne severity. As Cohen et al.7 showed that G2A may play 
a role in controlling immune response to gut commensal 
bacteria, we can speculate that patients with severe acne 
may either have dysregulated expression of G2A in re-
sponse to PA colonization or that the effects of G2A in 
acne patients may be an appropriate response to commen-
sal bacterium in the context of acne disease driven by oth-
er inflammatory pathways. Furthermore, while we were 
able to demonstrate a global upregulation of G2A ex-
pression in acne lesions, because of the inherent difficultly 
of obtaining acne lesion biopsies, our study was limited in 
its ability to relate G2A clinically. Rather, the scope of this 
study focused on the molecular mechanisms by which 
G2A may mediate innate immune response to PA and in-
troduce a mechanism by which lipids may mediate in-
flammatory in acne pathogenesis. 
In summary, we show that G2A is upregulated in acne le-
sions, and both G2A and its ligand are upregulated by PA 
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and may play an important anti-inflammatory function that 
quells pathogenesis to a commensal bacterium. Here we 
also introduce a possible pathway by which acne patho-
genesis is regulated by lipid mediators and help further 
understand the immune functions of G2A.
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Supplementary Fig. 1. Efficiency of GPR132 knockdown using 
small interfering RNA (siRNA). Transfection of THP-1 cells using 
siRNA and electroporation consistently yielded at least a 50% 
knockdown of GPR132 mRNA expression measured by 
quantitative polymerase chain reaction when compared to the 
control siRNA. 
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Supplementary Table 1. Quantitative polymerase chain reaction primer sequences
Gene Forward primer sequence Reverse primer sequence Accession number
gapdh TGCACCACCAACTGCTTAGC GGCATGGACTGTGGTCATGAG NM_001256799
gpr132 GGCTTTGCCATCCCTCTC GACAGGCACAGAAACACC NM_013345
il1b GCTTGGTGATGTCTGGTC GCTGTAGAGTGGGCTTATC NM_000576 
il6 CTGGATTCAATGAGGAGACTTG CACTACTCTCAAATCTGTTCTGG NM_000600 
il8 GACAGCAGAGCACACAAG AATCACTCTCAGTTCTTTG NM_000584 
il10 AGAAGCATGGCCCAGAAATC CTCTTCACCTGCTCCACTGC NM_000572.2
ppard AGCATCCTCACCGGCAAAG CCACAATGTCTCGATGTCGTG NM_001171818.1
